Evidence map›Paper›PMID 39101327›Full record

ArticleTexas Heart Institute journal2024

Valvular Endocarditis and Biventricular Heart Failure in the Setting of Tropheryma whipplei Disease.

Defne Gunes Ergi, Hind J Fadel, Hector I Michelena, Grace Lin, Kevin L Greason, Arman Arghami

Abstract readCase Reports
In one paragraph

Article in Texas Heart Institute journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Deciphering whipple's disease complexity.Clinical and experimental medicine · 2026
    Review
  2. Article
  3. Human genetics of Whipple's disease.Current opinion in rheumatology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Defne Gunes ErgiDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
Hind J FadelDepartment of Internal Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota.
Hector I MichelenaDepartment of Cardiology, Mayo Clinic, Rochester, Minnesota.
Grace LinDepartment of Cardiology, Mayo Clinic, Rochester, Minnesota.
Kevin L GreasonDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
Arman ArghamiDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whipple disease is a rare systemic illness associated with weight loss, diarrhea, and arthralgia. Asymptomatic carriage is common, but the disease can be complicated by cardiac involvement and may result in culture-negative endocarditis. Cardiac manifestations of the disease can lead to death. This report presents the case of a 66-year-old man with Whipple disease and biventricular heart failure with cardiogenic shock. Medical therapy followed by successful replacement of the aortic and mitral valves resulted in substantial improvement.

Indexed as

Endocarditis, BacterialHeart FailureHeart Valve Prosthesis ImplantationTropherymaWhipple DiseaseAgedAnti-Bacterial AgentsAortic ValveHeart Valve DiseasesHumansMaleMitral ValveShock, CardiogenicTreatment OutcomeAnti-Bacterial AgentsEndocarditisheart failureTropheryma

Identifiers

PMID39101327
PMCPMC11299065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.